Skip to main content
SpringerLink
Log in

Hyperthyroidism due to Graves’ disease and due to autonomous goiter

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

An attempt was made to classify 326 patients with hyperthyroidism due to Graves’ disease and due to autonomous goiter in an area of endemic iodine deficient goiter using the following two sets of criteria: 1) Primary criteria: the presence of endocrine ophthalmopathy (Graves’ disease) and the absence of endocrine ophthalmopathy and the absence of microsomal antibodies ≥: 1600 (autonomous goiter). Sixty-nine percent of the patients could be devided in the two groups with the aid of these criteria. 2) Secondary criteria: age > 50 years, presence of a goiter, presence of thyroid nodules, activity distribution in the scan, iodine intake determined by iodine excretion in the urine. These criteria had to be applied in the 31 % of the patients who could not be devided into one of the two groups using the primary criteria. The secondary criteria were accumulative. Using these criteria 55% of the 326 patients were classified as having Graves’ disease and 45% as having autonomous goiter. The probability of correct grouping when both primary and secondary criteria were applied was estimated to be 90% compared to 54% when we used only the classical terms, i.e. endocrine ophthalmopathy and diffuse goiter on the one hand and multinodular goiter without endocrine ophthalmopathy on the other hand. In a second group of 120 hyperthyroid patients classified in this way, thyrotropin displacing activity was determined independently. Its prevalence was 79% in patients classified as having Graves’ disease but only 3% in those classified as having autonomous goiter. The prevalence of TDA observed in patients who presumably had autonomous goiter was in the same range as in the following groups: 45 normal individuals; 126 patients with euthyroid goiter; and in 112 patients with euthyroid and hyperthyroid autonomous adenoma. Our results support the hypothesis that autonomous goiter in areas of endemic goiter due to iodine deficiency might not be of immunogenic origin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Volpe R. Auto-immunity in the endocrine system. Springer-Verlag, Berlin, Heidelberg, New York, 1981.

    Book  Google Scholar 

  2. Horster F.A., Klusmann G., Wildmeister W. Der Kropf: eine endemische Krankheit in der Bundesrepublik. Dtsch. Med. Wochenschr. 100: 8, 1975.

    Article  PubMed  CAS  Google Scholar 

  3. Schicha H., Emrich D. Immunogene und nicht immunogene Hyperthyreose. Dtsch. Med. Wochenschr. 108: 6, 1983.

    Article  PubMed  CAS  Google Scholar 

  4. Emrich D., Leipert K.-P., Schreivogel I., Facorro U., Köbberling J. Qualitätskontrolle und Normalbereiche für 10 Schilddrüsen in-vitro-Parameter. Akt. Endokr. Stoffw. 1:245,1980.

    CAS  Google Scholar 

  5. Metz C.E. Basic principles of ROC analysis. Semin. Nucl. Med. 8: 283, 1978.

    Article  PubMed  CAS  Google Scholar 

  6. Smith B.R., Hall R. Thyroid-stimulating immunoglobulins in Graves’ disease. Lancet 2: 427, 1974.

    Article  PubMed  CAS  Google Scholar 

  7. Dixon, W.J., Massey F.J. Introduction to statistical analysis, ed 3. McGraw-Hill Book Company, New York-San Francis-co-St. Louis-Toronto-London-Sydney, 1969.

    Google Scholar 

  8. Bolk J.H., Elte J.W.F., Bussemaker J.K., Haak A., v.d. Heide D. Thyroid-stimulating immunoglobulinsdonotcause non-autonomous, autonomous, or toxic multinodular goitres. Lancet 2: 61, 1979.

    Article  PubMed  CAS  Google Scholar 

  9. Bryson J.M., Joasoo A., Turtle J.R. The thyrotrophin receptor in human thyroid plasma membranes: effect of serum immunoglobulins. Acta Endocrinol. (Kbh.) 83: 528, 1976.

    CAS  Google Scholar 

  10. Croxson M.S., Lim T.M.T., Graham, F.M., Ibbertson H.K Thyroid stimulating immunoglobulins in health and disease. VIII Internat. Thyroid congress, Sydney-Australia, Abstract. 122, 1980.

    Google Scholar 

  11. Gardas A., Czarnocka B., Nauman J. The presence of autoantibodies directed to thyroid plasma membrane antigens in sera of patients with thyroid disorders, estimated by the reaction with labelled protein A. Acta Endocrinol. (Kbh.) 105: 500, 1984.

    CAS  Google Scholar 

  12. Hardisty C.A., Munro D.S. Relationship between long acting thyroid stimulator-protector (LATS-P) and the course of Graves’ disease. VIII Internat. Thyroid congress, Sydney-Australia, Abstract. 177, 1980.

    Google Scholar 

  13. McGregor A.M., Petersen M.M., Capiferri R., Evered D.C., Smith B.R., Hall R. Effects of radioiodine on thyrotrophin binding inhibiting immunoglobulins in Graves’ disease. Clin. Endocrinol. (Oxf.) 11: 437, 1979.

    Article  CAS  Google Scholar 

  14. Nitz D.W., Holstein P. Erste Ergebnisse mit einem neuen TSH-Rezeptor Antikörper-Assay. Der Nuklearmediziner 6: 111, 1983.

    Google Scholar 

  15. O’Donnel J., Trokoudes K., Silverberg J., Row V., Volpe R. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves’ disease. J. Clin. Endocrinol. Metab. 46: 770, 1978.

    Article  Google Scholar 

  16. Stöckle G., Wahl R., Seif F.J. Micromethod of human thyrocyte cultures for detection of thyroid-stimulating antibodies and thyrotrophin. Acta Endocrinol, (kbh.) 97: 369, 1981.

    Google Scholar 

  17. Gerber H., Peter H.J., Ramelli F., Miloni E., König M.P., Studer H., Berchtold R., Gemsenjäger E. Autonomie und Heterogenität der Follikel in der euthy-reoten und hyperthyreoten menschlichen Knotenstruma: die Lösung alter Rätsel? Schweiz. Med. Wochenschr. 113: 1178, 1983.

    PubMed  CAS  Google Scholar 

  18. Miller J.M., Horn R.C., Block M.A. The evolution of toxic nodular goitre. Arch, intern. Med. 113: 122, 1964.

    Article  Google Scholar 

  19. Miller J.M., Horn R.C., Block M.A. The autonomous functioning thyroid nodule in the evolution of nodular goitre. J. Clin. Endocrinol. Metab. 27: 1264, 1967.

    Article  PubMed  CAS  Google Scholar 

  20. Miller J.M., Block M.A. Functional autonomy in multinodular goiter. JAMA 214: 535, 1970.

    Article  PubMed  CAS  Google Scholar 

  21. Peter H.J., Studer H., Forster R., Gerber H. The pathogenesis of “hot” and “cold” follicles in multinodular goitres. J. Clin. Endocrinol. Metab. 55: 941, 1982.

    Article  PubMed  CAS  Google Scholar 

  22. Studer H., Bürgi H., König M.P. Die klinische Bedeutung der “sub-oder präklinischen” Hyperthyreose. Schweiz. Med. Wochenschr. 108: 2029, 1978.

    PubMed  CAS  Google Scholar 

  23. Emrich D., Bahre M. Autonomy in euthyroid goitre: maladaptation to iodine deficiency. Clin. Endocrinol. (Oxf.) 8: 257, 1978.

    Article  CAS  Google Scholar 

  24. Emrich D., Karkavitsas N., Facorro U., Schumbrand P., Schreivogel I., Schicha H., Dirks H. Influence of increasing iodine intake on thyroid function in euthyroid and hyperthyroid states. J. Clin. Endocrinol. Metab. 54: 1236,1982.

    Article  PubMed  CAS  Google Scholar 

  25. Blichert-Toft M., Christiansen C., Axelsson C.K., Egedorf J., Ibsen H., Ibsen J. Effect of selective goitre resection on absent thyrotropin response to thyrotrophin releasing hormone in idiopathic euthyroid goitres. Clin. Endocrinol. (Oxf.) 8: 95, 1978.

    Article  CAS  Google Scholar 

  26. Elte J.W.F., Wiarda K.S., Bussemaker J.K., Frölich M.,. Bolk J.H., v.d. Heide D., Haak A. Autonomously functioning euthyroid multinodular goitre. J. Mol. Med. 4:39, 1980.

    CAS  Google Scholar 

  27. Gemsenjäger E., Staub J.J., Girard J., Heitz Ph. Preclinical hyperthyroidism in multinodular goiter. J. Clin. Endocrinol. 43: 810, 1976.

    Article  Google Scholar 

  28. Smeulers J., Docter R., Visser T.J., Hennemann G. Response to thyrotrophin-releasing hormone and triiodothyronine suppressibility in euthyroid multinodular goitre. Clin. Endocrinol. (Oxf.) 7: 389, 1977.

    Article  CAS  Google Scholar 

  29. Blichert-Toft M., Christiansen C., Axelsson Ch., K., Egedorf J. TSH response pattern to TRH test and optimum time of blood sampling in sporadic euthyroid goitre. Acta Med. Scand. 204: 365, 1978.

    Article  PubMed  CAS  Google Scholar 

  30. Dige-Petersen H., Hummer L. Serum thyrotropin concentrations under basal conditions and after stimulation with thyrotropin-releasing hormone in idiopathic non-toxic goitre. J. Clin. Endocrinol. Metab. 44: 1115, 1977.

    Article  PubMed  CAS  Google Scholar 

  31. Elte J.W.F., Haak A., Frölich M., Wiarda K.S., van Wermeskerken R.K.A. Autonomously functioning euthyroid multinodular goitre. Neth. J. Med. 20: 1, 1977.

    PubMed  CAS  Google Scholar 

  32. Kirkegaard C., Faber J., Friis T., Lauridsen U.B., Rogowski P., Siersbaek-Nielsen K. Intravenous and peroral TRH stimulation in sporadic atoxic goitre. Acta Endocrinol. (Oxf.) 85: 508, 1977.

    CAS  Google Scholar 

  33. Bahre M., Emrich D. Funktionsszintigraphie der Schilddrüse. Akt. Endokr. Stoffw. 4: 66,1983.

    Google Scholar 

  34. Adams D.D., Kennedy T.H., Stewart J.C., Utiger R.D., Vidor G.I. Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin. J. Clin. Endocrinol. Metab. 47: 221, 1975.

    Article  Google Scholar 

  35. Blum M., Weinberg U., Shenkman L., Hollander C.S. Hyperthyroidism after iodinated contrast medium. N. Engl. J. Med. 291: 24, 1974.

    Article  PubMed  CAS  Google Scholar 

  36. Borak J. Jod und Basedow. Wien. Klin. Wochenschr. 38: 355, 1926.

    Google Scholar 

  37. Ek B., Johnsson S., Porat B. Iodide repletion test in an endemic goitre area. Risk of iodine-induced hyperthyroidism. Acta Med. Scand. 173: 341,1963.

    Article  Google Scholar 

  38. Ermans A.M., Camus M. Modifications of thyroid function induced by chronic administration of iodide in the presence of “autonomous” thyroid tissue. Acta Endocrinol. (Kbh.) 70: 463, 1972.

    CAS  Google Scholar 

  39. Herrmann J., Krüskemper H.L. Gefährdung von Patienten mit latenter und manifester Hyperthyreose durch jodhaltige Röntgenkontrastmittel und Medikamente. Dtsch. Med. Wochenschr. 103: 1434, 1978.

    Article  PubMed  CAS  Google Scholar 

  40. Kimball O.P. Induced hyperthyroidism. JAMA 85: 1709, 1925.

    Article  Google Scholar 

  41. Mahlstedt J., Joseph K. Dekompensation autonomer Adenome der Schilddrüse nach prolongierter Jodzufuhr. Dtsch. Med. Wochenschr. 98:1748,1973.

    Article  PubMed  CAS  Google Scholar 

  42. Reinwein D., Hackenberg K. Ungewöhnlich hohe Jodausscheidung bei Hyperthyreosen aus einem Jodmangelgebiet. Schweiz. Med. Wochenschr. 106: 377, 1976.

    PubMed  CAS  Google Scholar 

  43. Schicha H., Facorro U., Schumbrand P., Schreivogel I., Emrich D. Frequency of iodine contamination in a thyroid clinic. J. Mol. Med. 4: 177, 1980.

    Google Scholar 

  44. Schneider C., Stephan G., Suwelack M. Liber das Hyperthyreose-Risiko bei iatrogener Jodzufuhr. Dtsch. Med. Wochenschr. 94: 2631,1969.

    Article  PubMed  CAS  Google Scholar 

  45. Vidor G.I., Stewart J.C., Wall J.R., Wangel A., Hetzel B.S. Pathogenesis of iodine-induced thyrotoxicosis: studies in northern Tasmania. J. Clin. Endocrinol. Metab. 37: 901, 1973.

    Article  PubMed  CAS  Google Scholar 

  46. Becker W., Reiners Chr., Borner W. Klinische Erfahrungen mit dem TSH-Rezeptorautoanti-körper-Assay THYBIA. Nuc. Compact 74:289, 1983.

    Google Scholar 

  47. de Bruin T.W.A., v.d. Heide D., Querido A., Krol M.C. Direct and quantitative measurement by immunoprecip-itation assay of anti-thyrotrophin receptor antibodies in sera of patients with Graves’ disease. Clin. Endocrinol. (Oxf.) 20: 143, 1984.

    Article  Google Scholar 

  48. Nordmeyer J.P., Eickenbusch W. Bei Morbus Basectow TSH-Rezeptor-Autoantikörper nachweisbar. klinikarzt 13:215, 1984.

    Google Scholar 

  49. Schleusener H., Schernthaner G., Mayr W.R., Kotulla P., Bogner U., Finke R., Meinhold H., Koppenhagen K., Wenzel K.W. HLA-DR3 and HLA-DR5 associated thyrotoxicosis-two different types of toxic diffuse goiter. J. Clin. Endocrinol. Metab. 56: 781, 1983.

    Article  PubMed  CAS  Google Scholar 

  50. Brown R.S., Jackson I.M.D., Pohl S.L, Reichlin S. Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre? Lancet 1: 904,1978.

    Article  PubMed  CAS  Google Scholar 

  51. Smyth P.P.A., Neylan D., O’Donovan D.K. The prevalence of thyroid-stimulating antibodies in goitrous disease assessed by cytochemical section bioassay. J. Clin. Endocrinol. Metab. 54: 357, 1982.

    Article  PubMed  CAS  Google Scholar 

  52. Charkes N.D. Graves’ disease with functioning nodules (Marine-Len-hart syndrome). J. Nucl. Med. 13:885, 1972.

    PubMed  CAS  Google Scholar 

  53. Smyth P.P.A., Neylan D., O’Donovan D.K. Association of thyroid-stimulating immunoglobulins and thyrotropin-releasing hormone responsiveness in women with euthyroid goiter. J. Clin. Endocrinol. Metab. 57:1001, 1983.

    Article  PubMed  CAS  Google Scholar 

  54. Bidey S.P. Marshall N.J., Ekins R.P. Biossay of thyroid-stimulating immunoglobulins using human thyroid cell cultures: optimization and clinical assessment. Clin. Endocrinol. (Oxf.) 18: 193, 1983.

    Article  Google Scholar 

  55. Mukhtar E.D., Smith B.R., Pyle G.A., Hall R., Vice P. Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Lancet 1: 713, 1975.

    Article  PubMed  CAS  Google Scholar 

  56. Southgate K., Creagh F., Teece M., Kingswood C., Smith B.R. A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin. Endocrinol. (Oxf.) 20: 539,1984.

    Article  CAS  Google Scholar 

  57. Usadel K.K, Schumm P.-M., Wenisch H.J.C., Maul F.D. Neuer Bioassay zum Nachweis schilddrüsenstimulierender Immunoglobuline. Akt. Endokr. Stoffw. 5: 99, 1984.

    Google Scholar 

  58. Drexhage H.A., Bottazzo G.F., Doniach D., Bitensky L., Chayen J. Evidence for thyroid-growth-stimulating immunoglobulins in some goitrous thyroid diseases. Lancet 2: 287, 1980.

    Article  CAS  Google Scholar 

  59. Drexhage H.A., Bottazzo G.F., Doniach D. Thyroid growth stimulating and blocking immunoglobulins. In: Chayen J., Bitensky L. (Eds.), Cytochemical bioassays. Marcel Dekker Inc., New York and Basel, 1983, p. 153.

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nuclear Medicine, University of Göttingeri, Robert-Kock-Str. 40, D-3400, Göttingen, Federal Republic of Germany

    H. Schicha, D. Emrich & I. Schireivogel

Authors
  1. H. Schicha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Emrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Schireivogel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schicha, H., Emrich, D. & Schireivogel, I. Hyperthyroidism due to Graves’ disease and due to autonomous goiter. J Endocrinol Invest 8, 399–407 (1985). https://doi.org/10.1007/BF03348523

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348523

Key-words

Search

Navigation